Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104447739B details deuterated Palbociclib derivatives enhancing bioavailability. We offer scalable synthesis for reliable API intermediate supply chains.
Novel phosphite ester patent CN120504699A enables mild asymmetric hydrogenation. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN105017334A reveals single Λ-configuration cobalt catalysts. Enhances asymmetric synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN101659668A discloses novel routes for Irinotecan and Topotecan intermediates, offering significant cost reduction in API manufacturing through improved oxidation and alkylation strategies.
Patent CN112574225A details a room-temperature gold-catalyzed synthesis of tetrahydrofuran dihydroquinolines, offering high yields and simplified processing for pharmaceutical supply chains.
Patent CN103012319B reveals high-yield DEPBT method for repaglinide intermediates, ensuring supply chain stability and cost reduction.
Novel 3-step route using 2-amino-5-methylbenzoic acid ensures high purity >99% and cost reduction in obesity drug manufacturing.
Novel high-yield synthesis of LND1067 linker for ADCs. Optimized route avoids low-yield intermediates, ensuring cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN110067006A reveals metal-free electrochemical route for antitumor indoles, offering green manufacturing and supply chain advantages for pharma intermediates.
Patent CN103649055B reveals high-yield pyrazole synthesis for DPP-IV inhibitors, offering cost reduction and scalable supply chain solutions for pharma manufacturers.
Novel Cu-Ni catalytic method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers seeking stable production.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Novel Rh-catalyzed Zolpidem synthesis offers high purity and reduced toxic waste. Ideal for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Patent CN115141184A reveals acid-catalyzed route boosting yield to 70%, offering cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Discover a novel, metal-free synthesis method for oseltamivir phosphate. Eliminate sodium azide risks and palladium costs with our high-yield industrial process.
Novel rare earth catalyzed synthesis offers high yield and mild conditions for aminoisoindole derivatives, ensuring cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.